$0.49 -0.01 (-2.00%)
11/25/2009 9:54 AM

Generex Biotechnology Corp (GNBT)

CAPS Rating: 3 out of 5

The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.

Featured Broker Partners